Human Growth Hormone clinical trials
Also written Somatropin, Genotropin, Saizen® and LY137998.
How each study uses Human Growth Hormone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Human Growth Hormone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 16 Oct 1986 · HUMATROPE · BLA 019640 (FDA, Drugs@FDA)
- European Union
- 15 Feb 2001 · NutropinAq · EMEA/H/C/000315 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
Other names
Biosimilars
- Omnitrope
- 2
Studies by the year they started
210 studies that test it; most in 2005 (20); 1 more planned to start later
| Year | Studies |
|---|---|
| 1990 | 3 |
| 1991 | 1 |
| 1992 | 1 |
| 1993 | 2 |
| 1996 | 3 |
| 1997 | 4 |
| 1998 | 4 |
| 1999 | 5 |
| 2000 | 7 |
| 2001 | 6 |
| 2002 | 8 |
| 2003 | 14 |
| 2004 | 14 |
| 2005 | 20 |
| 2006 | 13 |
| 2007 | 9 |
| 2008 | 14 |
| 2009 | 5 |
| 2010 | 9 |
| 2011 | 6 |
| 2012 | 3 |
| 2013 | 6 |
| 2014 | 8 |
| 2015 | 7 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 118 · Other 99
Novo Nordisk A/S (34) · Changchun GeneScience Pharmaceutical Co., Ltd. (19) · Pfizer (18) · Merck KGaA, Darmstadt, Germany (11) · Eli Lilly and Company (10) · EMD Serono (8) · University of Aarhus (8) · Massachusetts General Hospital (6)
Often tested with
Tested in the same studies.
Testosterone (3) · Pegvisomant (3) · Insulin, Regular, Human (2) · Octreotide (2) · Glucagon (2) · Glucose (2) · Testosterone enanthate (2) · Propranolol (2)
Related medicines
As reviewed, each with the page that says it.
- One of Growth Hormone source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 6 phase 3 studies under way
Human Growth Hormone is the comparator. A study of two new drugs counts under both.
- 2Inpegsomatropin · Xiamen Amoytop Biotech Co., Ltd. · next primary completion Mar 2028
- 1Somapacitan · Novo Nordisk A/S
- 1Lonapegsomatropin · Ascendis Pharma A/S · next primary completion Feb 2028
- 1Somatrogon · Rabin Medical Center · next primary completion Dec 2027
Reaching primary completion within a year · 6, 1 in phase 3
Studies that test Human Growth Hormone, phase 3 first.
- Feb 2027Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)Phase 3 · VA Office of Research and Development
- Dec 2026Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)Phase 2 · Baylor College of Medicine
- Apr 2027Effects of Ketone Bodies on Insulin SensitivityNot applicable · University of Aarhus
- Apr 2027Phase IV Study of rhGH Injection in Adult Short Bowel SyndromePhase 4 · Changchun GeneScience Pharmaceutical Co., Ltd.
- Jun 2027Improving Tissue Repair After Injury in the Muscle-tendon Interface Muscle Tissue InjuryNot applicable · Bispebjerg Hospital
- Sep 2027Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT)Phase 4 · Anhui Provincial Hospital
Studies
Open first, then newest update. How each study uses Human Growth Hormone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 217
- Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in ChildrenRecruitingPhase 3Northwell HealthNCT06103513Written as Somatropin
- Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)RecruitingPhase 3VA Office of Research and DevelopmentNCT04867317Written as Somatropin
- Phase 3 Study to Evaluate the Efficacy and Safety of Human Growth Hormone Injection (Sinotropin AQ) for the Treatment of Children With Idiopathic Short StatureNot yet recruitingPhase 3Zhongshan Sansure Hygene Biomedicine Co., Ltd.NCT07815626Written as Human Growth Hormone (hGH)
- Phase IV Study of rhGH Injection in Adult Short Bowel SyndromeRecruitingPhase 4Changchun GeneScience Pharmaceutical Co., Ltd.NCT07691125Written as rhGH injection
- Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)RecruitingPhase 2Baylor College of MedicineNCT05355272Written as Recombinant human growth hormone
- Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite AthletesEnrolling by invitationNot applicableEnhanced Emirates LimitedNCT07568574Written as Human Growth Hormone (hGH)
- Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT)Not yet recruitingPhase 4Anhui Provincial HospitalNCT07481656Written as Recombinant Human Growth Hormone (rhGH) Injection
- Human Models of Selective Insulin Resistance: Pancreatic ClampNot yet recruitingPhase 1Columbia UniversityNCT06558422Written as Growth Hormone, Human
- Effects of Ketone Bodies on Insulin SensitivityRecruitingNot applicableUniversity of AarhusNCT07359625Written as Growth Hormone, Human
- Improving Tissue Repair After Injury in the Muscle-tendon Interface Muscle Tissue InjuryRecruitingNot applicableBispebjerg HospitalNCT05746650Written as Growth hormone (somatropin)
- A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Growth Hormone DeficiencyNot yet recruitingPhase 3Changchun GeneScience Pharmaceutical Co., Ltd.NCT06024967Written as PEG-somatropin
- The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian RespondersNot yet recruitingPhase 2/3Beni-Suef UniversityNCT05900661Written as Somatropin
- Growth Hormone Administration and the Human Immune SystemCompletedPhase 1National Institute on Aging (NIA)NCT00663611Written as Norditropin
- A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropin (Somatropin) Delivery and Taken up Into the Blood in Healthy AdultsCompletedPhase 1PfizerNCT07542886Written as Genotropin 4mg
- A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With AchondroplasiaCompletedPhase 4Changchun GeneScience Pharmaceutical Co., Ltd.NCT05353192Written as Recombinant human growth hormone
- Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR)Active, not recruitingPhase 1/2Dr. David WassersteinNCT07036003Written as Somatropin (recombinant human growth hormone)
- Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel SyndromeCompletedPhase 3Hospices Civils de LyonNCT00169637Written as rhGH
- Pancreatic Clamp in NAFLDCompletedPhase 1Columbia UniversityNCT05724134Written as Growth Hormone, Human
- Growth Hormone Therapy for Wasting in Cystic FibrosisTerminatedPhase 1University of Massachusetts, WorcesterNCT00803179Written as Nutropin AQ
- Impact of Recombinant Human Growth Hormone on HIV PersistenceCompletedPhase 2McGill University Health Centre/Research Institute of the McGill University Health CentreNCT03091374Written as Somatotropin (Human)
See all 217 studies that test Human Growth Hormone →
Given beside what is tested · 5 — Human Growth Hormone is usual care or a partner of the new treatment
- A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD)RecruitingPhase 1/2Changchun GeneScience Pharmaceutical Co., Ltd.NCT07264595Written as rhGH injection
- Dexamethasone/Pancreatic Clamp P&FWithdrawnPhase 1Columbia UniversityNCT06126354Written as Human Growth Hormone
- Growth Hormone and GnRH Agonist in Adolescents With Acquired HypothyroidismTerminatedPhase 4Baylor College of MedicineNCT00206375Written as Growth hormone treatment and puberty
- A Clinical Study in AGHD to Assess Safety, Tolerability and Efficacy of GX-H9CompletedPhase 2Genexine, Inc.NCT02946606Written as Genotropin
- Pharmacokinetics and Pharmacodynamics of ACP-001 (TransCon PEG hGH)CompletedPhase 1Ascendis Pharma A/SNCT01010425Written as Human Growth Hormone
As the comparator · 36 — what is tested is compared with Human Growth Hormone
- Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient DisordersRecruitingPhase 3Ascendis Pharma A/SNCT07221851Written as Somatropin Pen Injector
- A Phase 2 Study of Vosoritide in Children With Idiopathic Short StatureRecruitingPhase 2BioMarin PharmaceuticalNCT06382155Written as Human Growth Hormone
- The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational AgeRecruitingPhase 3Xiamen Amoytop Biotech Co., Ltd.NCT07309562Written as Recombinant Human Growth Hormone Injection
- Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.RecruitingPhase 3Rabin Medical CenterNCT07226089Written as Genotropin
- A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)RecruitingPhase 1Changchun GeneScience Pharmaceutical Co., Ltd.NCT07016802Written as Recombinant Human Growth Hormone Injection (Norditropin®)
- The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short StatureRecruitingPhase 3Xiamen Amoytop Biotech Co., Ltd.NCT06927310Written as Recombinant Human Growth Hormone Injection
- A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS)Not yet recruitingPhase 1/2Changchun GeneScience Pharmaceutical Co., Ltd.NCT07450053Written as Recombinant Human Growth Hormone Injection(Norditropin® FlexPro®)
- A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD)Not yet recruitingPhase 1/2Changchun GeneScience Pharmaceutical Co., Ltd.NCT07450001Written as Recombinant Human Growth Hormone Injection(Norditropin® FlexPro®)
- A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone DeficiencyNot yet recruitingPhase 3Changchun GeneScience Pharmaceutical Co., Ltd.NCT06007417Written as Genotropin
- A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day (REAL4)CompletedPhase 3Novo Nordisk A/SNCT03811535Written as Norditropin®
- A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a DayActive, not recruitingPhase 2Novo Nordisk A/SNCT03878446Written as Norditropin®
- A Safety, Pharmacokinetic and Pharmacodynamic Study of ACP-001 (TransCon hGH) in Adults With Growth Hormone DeficiencyCompletedPhase 2Ascendis Pharma A/SNCT01247675Written as Omnitrope
- Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)CompletedPhase 2Ascendis Pharma A/SNCT01947907Written as Human Growth Hormone
- A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone DeficiencyCompletedPhase 3Ascendis Pharma Endocrinology Division A/SNCT04615273Written as Somatropin
- A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to GrowActive, not recruitingPhase 3Novo Nordisk A/SNCT05330325Written as Norditropin®
- A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner SyndromeActive, not recruitingPhase 2Ascendis Pharma Endocrinology Division A/SNCT05690386Written as Somatropin
- A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day.CompletedPhase 3Novo Nordisk A/SNCT04970654Written as Norditropin®
- Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient ChildrenCompletedPhase 3OPKO Health, Inc.NCT02968004Written as Somatropin
- A Trial of YPEG-rhGH in Children With Short StatureCompletedPhase 2Xiamen Amoytop Biotech Co., Ltd.NCT05838885Written as rhGH
- rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 DeficiencyTerminatedPhase 2IpsenNCT00572156Written as NutropinAq® (Somatropin [rDNA origin])
Showing 20 of 36.
Codes
What other systems call Human Growth Hormone · ClinicalTrials.gg INT008700
- RxNorm 61148One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| RxNorm | 61148 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.